Adamis Pharmaceuticals Corporation
ADMP
$0.2113
-$0.0087-3.96%
Rating Factors
Growth Index
Efficiency Index
--
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/30/2023
-
Zolmax
1/30/2023
-
Zolmax
1/30/2023
-
Ticker Report
1/28/2023
-
Ticker Report
1/23/2023
-
Zolmax
1/22/2023
-
Ticker Report
1/15/2023
-
Zolmax
1/14/2023
-
Ticker Report
1/7/2023
-
Ticker Report
1/6/2023
-
Zolmax
1/4/2023
-
Ticker Report
12/30/2022
-
Ticker Report
12/29/2022
-
Zolmax
12/22/2022
-
Ticker Report
12/21/2022
-
Zolmax
12/20/2022
-
Zolmax
12/19/2022
-
Ticker Report
12/14/2022
-
Zolmax
12/13/2022
-
Ticker Report
12/6/2022
-
Ticker Report
12/5/2022
-
Zolmax
11/28/2022
-
Zolmax
11/27/2022
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 14, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Mar 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 997 2400
Address
11682 El Camino Real
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory...
more
